Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01412
|
|||||
| Drug Name |
Glycopyrrolate
|
|||||
| Synonyms |
GLYCOPYRROLATE; 596-51-0; Glycopyrrolate bromide; Robinul; Gastrodyn; Tarodyl; Nodapton; Tarodyn; Asecryl; Copyrrolate; Cuvposa; Glycopyrronii bromidum; AHR-504; ROBINUL FORTE; Robinal; Robanul; Bromuro de glicopirronio; Bromure de glycopyrronium; NVA-237; AHR 504; Glycopyrronii bromidum [INN-Latin]; EINECS 209-887-0; Bromure de glycopyrronium [INN-French]; Bromuro de glicopirronio [INN-Spanish]; 3-Hydroxy-1,1-dimethylpyrrolidinium bromide
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Airflow obstruction of chronic obstructive pulmonary disease [ICD11: CA22] | Approved | [1] | |||
| Therapeutic Class |
Anticholinergic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C19H28BrNO3
|
|||||
| Canonical SMILES |
C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-]
|
|||||
| InChI |
InChI=1S/C19H28NO3.BrH/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15;/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3;1H/q+1;/p-1
|
|||||
| InChIKey |
VPNYRYCIDCJBOM-UHFFFAOYSA-M
|
|||||
| CAS Number |
CAS 596-51-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 398.3 | Topological Polar Surface Area | 46.5 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| PubChem CID | ||||||
| PubChem SID |
794727
, 4582008
, 7351415
, 8152218
, 11466774
, 11467894
, 11486407
, 29222626
, 46509133
, 47275736
, 47720778
, 47869842
, 48318623
, 49699159
, 50124171
, 57321838
, 80767354
, 85209742
, 103825408
, 104234350
, 104303677
, 117554810
, 124893611
, 125081928
, 127431325
, 136023846
, 137008742
, 141652405
, 141652414
, 162108778
, 162459186
, 163366469
, 163368548
, 179150741
, 184685744
, 187051762
, 224504317
, 226501389
, 246480751
, 247320628
|
|||||
| ChEBI ID |
CHEBI:90972
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
| References | ||||||
| 1 | Glycopyrrolate was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.